# Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty

> **NCT06832878** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Mayo Clinic** · enrollment: 101 (estimated)

## Conditions studied

- Arthroplasty

## Interventions

- **DRUG:** Oral Tranexamic Acid

## Key facts

- **NCT ID:** NCT06832878
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 101 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06832878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06832878, "Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06832878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*